Vertex Pharmaceuticals has a 12 month low of $377.85 and a 12 month high of $519.88. The firm’s 50-day moving average is $434.90 and its 200 day moving average is $463.98.

Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' (VRTX.O), opens new tab drug to treat acute pain, the health regulator said on Thursday, offering a ...

Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...

1 Day VRTX -0.71% DJIA 0.38% S&P 500 0.53% Health Care/Life Sciences 0.19% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

How to Check SSC MTS Cut Off 2024? Candidates can download the SSC MTS cut off 2024 in a PDF format on the official website. Here is the step-by-step guide to check the SSC MTS exam Cut Off 2024 ...

Marvel Rivals players want Magneto's Iron Volley to not require reloading for increased damage. Other suggestions include preventing Magneto's Meteor M overload and unique character reload mechanics.

Some Marvel Rivals players believe that Magneto's ultimate ability, Meteor M, is bugged. A new video shows the attack passing through an enemy target without dealing any damage. Players are hoping ...

Citron, one of the last active Switch emulators, just got a big update. Focused on compatibility, the update makes the most popular games play better. Developers claim most games now run perfectly ...